Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Schisandrins has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
A schisandrin-class isolate and a standardised berry extract deliver overlapping material, one as a purified fraction and one inside the whole fruit profile. The whole extract also brings organic acids and polysaccharides the fraction lacks. Anyone taking both should count total lignan intake rather than assuming the two are separate ingredients. The pairing is a formulation choice.
Dibenzocyclooctadiene lignans partition into fat far better than into gut fluid, so exposure is higher when they are taken with a fat-containing meal or dispersed in oil. A fish oil softgel is one convenient vehicle; any dietary fat drives the same physics. There is no chemical interaction between the two ingredients. Read this as a delivery point rather than a combined effect.
Nrf2 activation raises expression of glutamate-cysteine ligase and glutathione S-transferases, which is upstream of the glutathione pool. Supplementing glutathione addresses the pool directly, though oral glutathione is itself poorly absorbed intact. The two hit the same system from opposite ends. This is characterised in vitro, not as a combination outcome in people.
Lipoic acid cycles between oxidised and reduced forms and hands electrons back into the cellular antioxidant network. Lignan-driven enzyme induction raises the capacity of that network rather than its immediate reducing power. On mechanism the two are complementary. No human combination data exist, so this is a formulation rationale.
Silymarin and Schisandra lignans reduce hepatocyte oxidative stress markers in rodent work by partly separate routes, and the two are combined routinely in commercial formulas. Human combination evidence is thin. Both also modulate drug-metabolising enzymes, so the pairing compounds that interaction rather than cancelling it. That is the point worth flagging to anyone on prescription medicines.
Schisandra and rhodiola appear together in the classic three-herb adaptogen combinations described in Soviet-era research and carried into modern products. The category itself is defined pharmacologically loosely. Whether the combination outperforms either alone has not been established in controlled human work. The pairing is convention and tradition, not a demonstrated interaction.
Different lignans in this class have shown inhibition and induction of cytochrome enzymes depending on dose and exposure duration. Where CYP1A2 slows, caffeine persists longer at the same intake. This has been observed in animal and in vitro systems rather than measured as caffeine kinetics in people. Anyone sensitive to caffeine should regard the pairing as unpredictable rather than neutral.
Nothing specific on file for Schisandrins. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.